Mohan Bala
2023
In 2023, Mohan Bala earned a total compensation of $1.6M as Senior Vice President, Chief Development Officer at Mersana Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $111,930 |
|---|---|
| Option Awards | $762,804 |
| Salary | $430,500 |
| Stock Awards | $269,100 |
| Other | $7,000 |
| Total | $1,581,334 |
Bala received $762.8K in option awards, accounting for 48% of the total pay in 2023.
Bala also received $111.9K in non-equity incentive plan, $430.5K in salary, $269.1K in stock awards and $7K in other compensation.
Rankings
In 2023, Mohan Bala's compensation ranked 738th out of 2,878 executives tracked by ExecPay. In other words, Bala earned more than 74.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 738 out of 2,878 | 74th |
Division Manufacturing | 427 out of 1,582 | 73rd |
Major group Chemicals And Allied Products | 291 out of 891 | 67th |
Industry group Drugs | 285 out of 854 | 67th |
Industry Pharmaceutical Preparations | 188 out of 614 | 69th |
Source: SEC filing on April 26, 2024.
Bala's colleagues
We found six more compensation records of executives who worked with Mohan Bala at Mersana Therapeutics in 2023.
2023
Anna Protopapas
Mersana Therapeutics
Chief Executive Officer
2023
Martin Huber
Mersana Therapeutics
Chief Executive Officer
2023
Arvin Yang
Mersana Therapeutics
Chief Medical Officer
2023
Brian DeSchuytner
Mersana Therapeutics
Chief Financial Officer
2023
Timothy Lowinger
Mersana Therapeutics
Senior Vice President, Chief Science and Technology Officer
2023
Alejandra Carvajal
Mersana Therapeutics